Retrieved from What is Lipo-B injection and what is it used for
Understanding how it functions offers insight into aging, disease prevention, and overall health
Glucagon-like Peptide-1 Receptor Agonists and the Risk of Acute Kidney Injury: Alarming, or Not
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
Friendly Safety Note: This service may not be appropriate for everyone
however, nonantimicrobial sulfonamides do not need to be avoided